Peroxisome proliferator-activated receptors (PPAR)-g belongs to the nuclear hormone receptor superfamily of ligand-dependent transcription factors and may be relevant for lung cancer therapy (see review, [70]). This evidence concerns the gene NR0B1 and lung carcinoma.